The location of the catalytic site of the membrane-bound respiratory fumarate reductase of Escherichia coli was investigated using mutants and inhibitors of dicarboxylic acid transport.
INTRODUCTION
Escherichia cofi grows anaerobically on several non-fermentable substrates when fumarate is provided as an electron acceptor. The respiratory chain developed under these growth conditions is terminated by a membrane-bound fumarate reductase (EC 1.3.99.1) . It is important to determine whether fumarate i s reduced in the cytoplasm or in the periplasm, so that the inter-relationship between the organization of the respiratory chain and its protontranslocating ability can be understood.
Direct evidence that the fumarate reductase enzyme complex is at least in part located on the cytoplasmic side of the membrane has been presented by a number of workers using immunological and electron microscopic methods (Van der Plas et of., 1983; Lemire et a/., 1983). However, the location of the catalytic site of a membrane-bound enzyme need not be the same as that of the bulk of the enzyme protein as detected by non-enzymic means. In this paper, fumarate reduction by intact cells and membrane particles has been measured in dicarboxylic acid transport mutants and with inhibitors of dicarboxylic acid transport present, in order to determine the location of the catalytic site.
METHODS
Growrk oforgunism. The organisms used in this study are listed in Table I . Bacteria were grown anaerobically at 37 "C in 500 mi bottles filled to the neck with either the glycerol/fumaratc medium of Spencer Bt Guest (1973) or with nutrient broth containing glucose (0-5%, wlv). Bacteria were harvested by centrifugation (SSOOg, I5 min) after 18 h, washed twice in potassium phosphate buffer (50 mM, pH 7.5) and resuspcnded in the same buffer.
Prepururion of niembrum particles. Invened membrane particles were prepared by French pressure cell treatment as described by Reid & lngledew (1979) .
Enzyme ossuys. Rates of O2 consumption were measured at 30 "C in a Clark-type O2 electrode. The buffer used was potassium phosphate (50 rnw, pH 7.9, all substrates were 5 mM (final concentration) and the cells or membrane particles were approximately 0-25 mg protein m1-I (final concentration in a 3 ml reaction volume).
Fumarate reductase activity was measured spectrophotometrically at 30 "C by following the rate of oxidation of reduced bcnzyl viologen, using the method of Spencer & Guest (1973) modified as follows. Benzyl viologen ( I 20 p~) was reduced by titration with a freshly prepared saturated solution of sodium dithionite, to give an absorbance at 550 nm of04 to 0.9. Fumarate and C,dicarboxylic acids were then added and the rate of basal oxidation was followed for 5 min before the reaction was initiated by the addition of cells or membrane particles (0.25 mg protein ml-' and 7.0 pg protein rnl-', respcctively). The buffer used was potassium phosphate (50 mw, pH 7.5) 
RESULTS
Fumarate reductase activities of intact cells and membrane particles of E. cofi were compared in order to determine any requirement for a transport process for fumaratc. Two experimental approaches were used. Firstly, fumarate reductase activities in a number of strains, some of which lacked the dicarboxylic acid carrier (dct mutants) were compared; and secondly, fumarate reductase activities in the presence of inhibitors of the dicarboxylic acid carrier were measured. Fumarate reductase activity was assayed by measuring the oxidation of reduced benyl viologen. Jones 8t Garland (1977) have shown that reduced benzyl viologen can readily cross the cytoplasmic membrane of E. coli K12.
Studies with dct mutants
Fumarate reductasc activities in intact bacteria and membrane particles derived from dct mutant strains were compared with those of the wild-type. The dct mutants could not grow by fumarate respiration, so all strains were grown on nutrient broth for these experiments. This mode of growth had the disadvantage of yielding lower activities for both the fumarate reductase and (where present) the dicarboxylic acid carrier. Substantial rates of fumaratc reductase activity were detected in the intact cells of strains EMGZ and JRG1031, but there was no activity observed in the mutants CBT38, CBT3 12 and CBT3 I 3 ( Table 2 ). The membrane particles of all strains had fumarate reductase activity. The fumarate reductase activity was greatest in the strain containing amplification of thefid gene (JRG1031). Comparison of the rates of fumarate reduction by cells and membrane particles showed that fumarate reductase activity was masked in intact cells of all strains except EMG2 ( Table 2) . NADH oxidase activities were also measured with the membrane preparations to give an indication of membrane integrity. A functional electron transport chain was shown in all preparations. NADH oxidase was not measured with whole cells. The apparent relationship between the NADH oxidase and fumarate reductase activities may be due to NADH dehydrogenase acting as an electron donor to the electron transport chain when fumarate reductase is the major site of terminal electron transfer. In strain IRG 103 I, the rate of fumarate reduction in whole cells was high, but the specific activity in the membranes was tenfold greater, presumably because a rate limitation imposcd by the transport process was removed in the latter case. In the dct mutants no activity was observed in intact cells, presumably because the fumarate could not enter. These observations show the requirement for a dicarboxylic acid carrier in whole cells but not in particles, indicating that the site of fumarate reduction is cytoplasmic.
Fumamte reductuse activities in the presence and absence of inhibitors E. coli strains EMGZ and JRG I031 were grown in glycerol/fumarate medium, which enables growth by fumarate respiration and induces high activities of fumarate reductasc (Spencer & Guest, 1973) . Maximum rates ( V,,,,,) and K, values were determined graphically (Table 3) scribed in Methods. In the glycerol/fumarate-grown strain EMG2 there was no significant difference between these values in cells and membrane particles in the absence of an inhibitor. In strain JRG1031, a K, value of 0.25 m~ for fumarate was observed in the membrane preparation, close to that obtained in EMG2, but a K, value of 0-78 m~ was observed for whole cells. Presumably the K, of 0.25 mM was a consequence of rate limitation of fumarate reductase itself, so in EMGZ cells and membranes and in JRG1031 membranes the reductase step was rate-limiting In strain JRG 1031, the fumarate reductase is amplified and appeared to cause the porter for fumarate entry to become rate-limiting in whole cells. Thus the K, of 0-78 mM reflects the affinity of the dicarboxylic acid carrier, rather than the fumarate reductase, for fumarate.
The use of aspartate, malate and tartrate as inhibitors of either the dicarboxylic acid carrier or fumarate reductase confirmed the need for a dicarboxylic acid carrier for fumarate reduction in intact cells (Table 3) . Aspartate did not inhibit fumarate reduction by membrane particles, but it was effective as a competitive inhibitor in whole cells. Our interpretation of these results is that aspartate is an inhibitor of the transport process (Kay & Kornberg, 1971) but not of fumarate reductase, and hence is an inhibitor of furnarate reduction only in intact cells. Tartrate had only a marginal effect on fumarate reductase activity in whole cells, but was a competitive inhibitor of fumarate reductase activity in membrane particles. Malate inhibited in both cells and membrane preparations. In control experiments, no detectable oxidase activities were observed for aspartate, malate and tartrate in membrane preparations or cells (using an O2 electrode). Only
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malate supported benzyl viologen oxidation, and then only in whole cells. The rates of malatesupported viologen oxidation were 78 f 6 nmol min-' (mg protein)-' for strain JRGl031 and 82 f 5 nmol min" (mg protein)-' for strain EMG2, indicating the presence of fumarase activity in whole cells. This complicates the interpretation of the data obtained with whole cells in the presence of malate (values in parentheses in Table 3 ). However, the K, for fumarate was increased in the presence of malate, showing that the primary effect of malate on fumarate reduction in whole cells was to inhibit fumarate reduction at the level of the dicarboxylic acid porter. If the conversion of malate to fumarate had distorted the results (initial rates were measured) then, in the absence of any other effect, an apparent lowering of the K, for fumarate would result.
These studies, using dcf mutants and inhibitors of the dicarboxylic acid carrier and fumarate reductase, show that in whole cells the transmembrane transport of fumarate must precede its reduction. Thus the catalytic site of the fumarate reductase must be located on the cytoplasmic aspect of the cytoplasmic membrane.
Van der Plas et al. (1983) used a crossed immuno-electrophoretic approach to analyse the membrane proteins of E. culi grown on glycerol with fumarate as respiratory oxidant and extended their analysis to immuno-absorption studies. By comparing the antibody binding to intact (right-side out) and disrupted membrane vesicles, they calculated the relative expression of the fumarate reductase antigen at the external and internal membrane surfaces, It was concluded that the antigenic determinants of E. coli fumarate reductase were located on the cytoplasmic aspect of the cytoplasmic membrane. The location of the catalytic site was not determined, however, and the absence of antigenic determinants from the periplasrnic aspect of the membrane cannot be taken as conclusive proof of the absence of any part of the fumarate reductase from this side of the membrane.
Lemire ef al. (1983) attempted to determine the structure of fumarate reductase in inverted membrane vesicles by a combination of antibody binding studies and electron microscopy. They identified 'knob-like' structures, observed on the cytoplasmic side of the cytoplasmic membrane, with the catalytic subunits of fumarate reductase, since removal of the fumarate reductase activity from the membrane preparation by chymotrypsin or urea treatment and restoration by incubation of the stripped membranes with a fumarate reductase preparation resulted in a corresponding loss and reappearance of the 'knobs'. This work indicated that the bulk of the fumarate reductase is mcmbrane-associated and located on the cytoplasmic aspect of the membrane, and thus implied that the catalytic site is also cytoplasmic. However, the possibility that the major part of the enzyme is located cytoplasmicaliy, yet the substrate site is still accessible from the periplasmic phase, could not be ruled out.
Jones & Garland (1977) assumed a cytoplasmic location for fumarate reductase on the basis of the abilities of oxidation-reduction dyes to reduce fumarate in intact and broken cells, but this approach suffered from a lack of knowledge of the site of interaction between the dyes and the respiratory chain. Gutowski & Rosenberg (1976 ,1977 also argued for an internal location of the fumarate reductase catalytic site on the basis of the effect of tartrate on respiratory proton translocation supported by a pulse of fumarate. The conclusion that the quenching of the acidification was due to an inhibition of the transport process by tartrate can be questioned on two points. Firstly, tartrate is a better inhibitor of fumarate reductase than of the dicarboxylic acid carrier. Secondly, tartrate would be expected to quench the measured proton translocation by entering the cell in symport with a proton as soon as any ApH is established, because the dicarboxylic acid carrier is a proton symporter (Gutowski & Rosenberg, 1976) .
In this paper we have presented evidence that the catalytic site of fumarate reductase is situated on the cytoplasmic aspect of the cytoplasmic membrane, by demonstrating a requirement for a functional dicarboxylic acid carrier to support both fumarate reduction in whole cells and growth with fumarate as terminal electron acceptor. This complements the findings of others which showed that the bulk of the enzyme protein was similarly located.
